BUSINESS● LOW3h ago · Sep 17, 2026, 4:06 PM
BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs
Yahoo Finance · global
BioCryst has reported its first profit and plans to acquire rare disease drugs. This marks a significant financial milestone and strategic shift for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS33m agoYieldMax CRCL Option Income Strategy ETF declares $0.2373 dividendSeeking Alpha TechBUSINESS34m agoYieldMax COIN Option Income Strategy ETF declares $0.2996 dividendSeeking Alpha Tech